<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
  xmlns:dc="http://purl.org/dc/elements/1.1/"
  xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
  xmlns:admin="http://webns.net/mvcb/"
  xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">

<channel>
<title>In the Pipeline</title>
<link>/home/corante/public_html/pipeline/</link>
<description></description>
<dc:language>en-us</dc:language>
<dc:creator>derekb.lowe@gmail.com</dc:creator>
<dc:date>2011-04-15T07:51:40-05:00</dc:date>
<admin:generatorAgent rdf:resource="http://www.movabletype.org/?v=3.34" />
<sy:updatePeriod>hourly</sy:updatePeriod>
<sy:updateFrequency>1</sy:updateFrequency>
<sy:updateBase>2000-01-01T12:00+00:00</sy:updateBase>

<item>
<title>Selenium In a Drug Structure: Why Not?</title>
<link>http://pipeline.corante.com/archives/2011/04/15/selenium_in_a_drug_structure_why_not.php</link>
<description>You don&apos;t see too many drugs with selenium in them, that&apos;s for sure. It&apos;s one of those elements that can be used to illustrate the Paracelsian doctrine that the dose makes the poison: selenium is an essential element that&apos;s also...</description>
<guid isPermaLink="false">74953@/home/corante/public_html/pipeline/</guid>
<dc:subject>Odd Elements in Drugs</dc:subject>
<dc:date>2011-04-15T07:51:40-05:00</dc:date>
</item>
<item>
<title>You Don&apos;t See Many Names Starting with &quot;Tellura-&quot;</title>
<link>http://pipeline.corante.com/archives/2010/05/13/you_dont_see_many_names_starting_with_tellura.php</link>
<description>When I wrote here about unknown compounds, using aza-steroids as examples, I apparently wasn&apos;t thinking far enough afield. I noticed this new paper on a new class of tellura-steroids. I&apos;ve no doubt that they&apos;re new; probably no one has ever...</description>
<guid isPermaLink="false">74469@/home/corante/public_html/pipeline/</guid>
<dc:subject>Chemical News</dc:subject>
<dc:date>2010-05-13T13:11:10-05:00</dc:date>
</item>
<item>
<title>Ozonides As Drugs: What Will They Think of Next?</title>
<link>http://pipeline.corante.com/archives/2009/11/23/ozonides_as_drugs_what_will_they_think_of_next.php</link>
<description>You know, I often think that I have too narrow a view of what kinds of structures can go into drug molecules. (That may come as worrisome statement for some past and present colleagues of mine, who feel that my...</description>
<guid isPermaLink="false">74157@/home/corante/public_html/pipeline/</guid>
<dc:subject>Odd Elements in Drugs</dc:subject>
<dc:date>2009-11-23T08:13:48-05:00</dc:date>
</item>
<item>
<title>One For the Brave</title>
<link>http://pipeline.corante.com/archives/2007/11/02/one_for_the_brave.php</link>
<description>I was interested to see a recent paper in Organic Letters on a class of compounds I&apos;d never seen before: 1,2-dihydro-1,2-azaborines. There&apos;s the structure, in case that doesn&apos;t immediately call something to mind. These things, which are isoelectronic with benzene,...</description>
<guid isPermaLink="false">72832@/home/corante/public_html/pipeline/</guid>
<dc:subject>Chemical News</dc:subject>
<dc:date>2007-11-02T09:36:23-05:00</dc:date>
</item>
<item>
<title>Arsenic, Patents, and the World</title>
<link>http://pipeline.corante.com/archives/2007/09/17/arsenic_patents_and_the_world.php</link>
<description>As I was mentioning the other day, the latest issue of Nature Medicine has the details on a story that doesn’t, on the face of it, do the industry any credit. About twenty years ago, there were reports out of...</description>
<guid isPermaLink="false">72681@/home/corante/public_html/pipeline/</guid>
<dc:subject></dc:subject>
<dc:date>2007-09-17T08:25:59-05:00</dc:date>
</item>
<item>
<title>My Shopping List</title>
<link>http://pipeline.corante.com/archives/2006/01/08/my_shopping_list.php</link>
<description>Some time ago I wrote about some atoms that I wish I could use. There are still other molecular fragments that Nature has neglected to provide, though, and I&apos;m adding to the wish list: First off, I&apos;d like some groups...</description>
<guid isPermaLink="false">45740@/home/corante/public_html/pipeline/</guid>
<dc:subject>Odd Elements in Drugs</dc:subject>
<dc:date>2006-01-08T23:05:29-05:00</dc:date>
</item>
<item>
<title>Odd Elements in Drugs: Silicon</title>
<link>http://pipeline.corante.com/archives/2004/05/02/odd_elements_in_drugs_silicon.php</link>
<description>Another chemical element that you don&apos;t see much in pharmaceuticals is silicon. Hey, it&apos;s right under carbon in the periodic table, and forms four tetrahedral bonds just like carbon does, so why not, eh? Now, if you&apos;re like me, you...</description>
<guid isPermaLink="false">10947@/home/corante/public_html/pipeline/</guid>
<dc:subject>Drug Development</dc:subject>
<dc:date>2004-05-02T21:54:16-05:00</dc:date>
</item>
<item>
<title>Odd Elements in Drugs</title>
<link>http://pipeline.corante.com/archives/2004/04/19/odd_elements_in_drugs.php</link>
<description>I had a question recently about why some chemical elements don&apos;t appear much in pharmaceuticals. Boron was one example - the first boron-containing drug (Velcade, from Millennium) was approved just recently. But it hasn&apos;t been for lack of trying. Starting...</description>
<guid isPermaLink="false">10936@/home/corante/public_html/pipeline/</guid>
<dc:subject>Odd Elements in Drugs</dc:subject>
<dc:date>2004-04-19T21:25:38-05:00</dc:date>
</item>


</channel>
</rss>
